Literature DB >> 27811337

Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.

Janine Mikolajczak1, Hanna Zimmermann1, Ahmad Kheirkhah2, Ella Maria Kadas1, Timm Oberwahrenbrock1, Rodrigo Muller2, Aiai Ren2, Joseph Kuchling1, Holger Dietze3, Harald Prüss4, Friedemann Paul5, Pedram Hamrah6, Alexander U Brandt1.   

Abstract

BACKGROUND: Many studies in multiple sclerosis (MS) have investigated the retina. Little, however, is known about the effect of MS on the cornea, which is innervated by the trigeminal nerve. It is the site of neural-immune interaction with local dendritic cells reacting in response to environmental stimuli.
OBJECTIVE: This study aims to investigate the effect of MS on corneal nerve fibres and dendritic cells in the subbasal nerve plexus using in vivo confocal microscopy (IVCM).
METHODS: We measured the corneal nerve fibre and dendritic cell density in 26 MS patients and matched healthy controls using a Heidelberg Retina Tomograph with cornea module. Disease severity was assessed with the Multiple Sclerosis Functional Composite, Expanded Disability Status Scale, visual acuity and retinal optical coherence tomography.
RESULTS: We observed significant reduction in total corneal nerve fibre density in MS patients compared to controls. Dendritic cell density was similar in both groups. Reduced total nerve fibre density was associated with worse clinical severity but not with previous clinical trigeminal symptoms, retinal neuro-axonal damage, visual acuity or disease duration.
CONCLUSION: Corneal nerve fibre density is a promising new imaging marker for the assessment of disease severity in MS and should be investigated further.

Entities:  

Keywords:  Multiple sclerosis; cornea; peripheral nerves; retina; subbasal nerve plexus; trigeminal neuralgia

Mesh:

Substances:

Year:  2016        PMID: 27811337      PMCID: PMC5513781          DOI: 10.1177/1352458516677590

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  36 in total

1.  In vivo confocal microscopic evaluation of langerhans cell density and distribution in the corneal epithelium of healthy volunteers and contact lens wearers.

Authors:  Andrey Zhivov; Joachim Stave; Brigitte Vollmar; Rudolf Guthoff
Journal:  Cornea       Date:  2007-01       Impact factor: 2.651

2.  Trigeminal neuralgia in multiple sclerosis.

Authors:  J P Hooge; W K Redekop
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

3.  Unilateral herpes zoster ophthalmicus results in bilateral corneal nerve alteration: an in vivo confocal microscopy study.

Authors:  Pedram Hamrah; Andrea Cruzat; Mohammad H Dastjerdi; Harald Prüss; Lixin Zheng; Bashar M Shahatit; Hasan A Bayhan; Reza Dana; Deborah Pavan-Langston
Journal:  Ophthalmology       Date:  2012-09-19       Impact factor: 12.079

4.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 5.  Neuropathic pain in the general population: a systematic review of epidemiological studies.

Authors:  O van Hecke; Sophie K Austin; Rafi A Khan; B H Smith; N Torrance
Journal:  Pain       Date:  2013-11-26       Impact factor: 6.961

6.  Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.

Authors:  Shiv Saidha; Elias S Sotirchos; Mohamed A Ibrahim; Ciprian M Crainiceanu; Jeffrey M Gelfand; Yasir J Sepah; John N Ratchford; Jiwon Oh; Michaela A Seigo; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Ari J Green; Quan D Nguyen; Peter A Calabresi
Journal:  Lancet Neurol       Date:  2012-10-04       Impact factor: 44.182

7.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

8.  Multiple sclerosis associated with peripheral demyelinating neuropathy.

Authors:  G Di Trapani; A Carnevale; R P Cioffi; A R Massaro; P Profice
Journal:  Clin Neuropathol       Date:  1996 May-Jun       Impact factor: 1.368

Review 9.  Vision and vision-related outcome measures in multiple sclerosis.

Authors:  Laura J Balcer; David H Miller; Stephen C Reingold; Jeffrey A Cohen
Journal:  Brain       Date:  2014-11-28       Impact factor: 13.501

View more
  28 in total

1.  Use of Corneal Confocal Microscopy to Detect Corneal Nerve Loss and Increased Dendritic Cells in Patients With Multiple Sclerosis.

Authors:  Gulfidan Bitirgen; Zehra Akpinar; Rayaz A Malik; Ahmet Ozkagnici
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

2.  Conjunctival impression cytology and tear film parameters in patients with multiple sclerosis.

Authors:  Selman Belviranli; Pembe Oltulu; Ali Ulvi Uca; Ali Osman Gundogan; Enver Mirza; Mustafa Altas; Nazli Turk; Refik Oltulu
Journal:  Int Ophthalmol       Date:  2021-10-01       Impact factor: 2.031

3.  Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.

Authors:  Alexandra Marquez; Lucie S Guernsey; Katie E Frizzi; Morgan Cundiff; Isabel Constantino; Nabeel Muttalib; Fernanda Arenas; Xiajun Zhou; Sze Hway Lim; Maryam Ferdousi; Georgios Ponirakis; Monty Silverdale; Christopher Kobylecki; Matthew Jones; Andrew Marshall; Rayaz A Malik; Corinne G Jolivalt
Journal:  Neurobiol Dis       Date:  2021-01-19       Impact factor: 5.996

Review 4.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

5.  Peripheral neuropathy in patients with multiple sclerosis.

Authors:  Adnan Khan; Saadat Kamran; Georgios Ponirakis; Naveed Akhtar; Rabia Khan; Pooja George; Blessy M Babu; Faiza M Ibrahim; Ioannis N Petropoulos; Beatriz G Canibano; Stacy S Wilins; Dirk Deleu; Ashfaq Shuaib; Rayaz A Malik
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

6.  Deep learning-based analysis of macaque corneal sub-basal nerve fibers in confocal microscopy images.

Authors:  Jonathan D Oakley; Daniel B Russakoff; Megan E McCarron; Rachel L Weinberg; Jessica M Izzi; Stuti L Misra; Charles N McGhee; Joseph L Mankowski
Journal:  Eye Vis (Lond)       Date:  2020-05-08

Review 7.  Potential use of corneal confocal microscopy in the diagnosis of Parkinson's disease associated neuropathy.

Authors:  Ning-Ning Che; Hong-Qi Yang
Journal:  Transl Neurodegener       Date:  2020-07-02       Impact factor: 8.014

Review 8.  A Review of Imaging Biomarkers of the Ocular Surface.

Authors:  William W Binotti; Betul Bayraktutar; M Cuneyt Ozmen; Stephanie M Cox; Pedram Hamrah
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

9.  Discrepancy between NTG and POAG with corneal nerves in CCM.

Authors:  Dl Jing; Zy Liu; Yl Chou; Hk Wang; S Gao; X Fan; W Wang
Journal:  Eye (Lond)       Date:  2021-08-02       Impact factor: 4.456

10.  The Utility of Corneal Nerve Fractal Dimension Analysis in Peripheral Neuropathies of Different Etiology.

Authors:  Ioannis N Petropoulos; Abdulrahman Al-Mohammedi; Xin Chen; Maryam Ferdousi; Georgios Ponirakis; Harriet Kemp; Reena Chopra; Scott Hau; Marc Schargus; Jan Vollert; Dietrich Sturm; Tina Bharani; Christopher Kleinschnitz; Mark Stettner; Tunde Peto; Christoph Maier; Andrew S C Rice; Rayaz A Malik
Journal:  Transl Vis Sci Technol       Date:  2020-08-28       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.